New Tools for Alzheimer's Disease Research【ABBIOTEC】
Alzheimer's disease (AD) is the most common form of dementia for people over 65 years of age. AD is associated with formation of amyloid plaques and neurofibrillary tangles in the brain. Numerous cellular pathways are investigated for early diagnosis, treatment and symptoms management. Abbiotec offers over 200 antibodies, peptides and proteins for studying the detection, progression, treatment, and cell signaling events associated with AD. Browse our catalog for rabbit, mouse and rat antibodiesthat are developed for ELISA, western blot, IHC and immunofluorescence applications.
622 人阅读发布时间:2016-02-18 09:36